By Iain Gilbert
Date: Friday 20 Feb 2026
(Sharecast News) - Life science business SkinBioTherapeutics said on Friday that it has appointed Alyson Levett as a new non‑executive director and chair of the audit committee, with responsibility for overseeing the ongoing investigation into the conduct of its former chief executive and the validity of royalty income booked in its FY25 accounts.
| Holding(s) in Company | 20-Feb-2026 | 17:40 | RNS |
| Director’s Dealing | 20-Feb-2026 | 17:15 | RNS |
| Holding(s) in Company | 20-Feb-2026 | 16:06 | RNS |
| Director/PDMR Shareholding | 20-Feb-2026 | 15:30 | RNS |
| Form 8.3 - Oxford Biomedica plc | 20-Feb-2026 | 15:20 | RNS |
| Questor :GW Pharmaceuticals | 04-Dec-2014 | Telegraph |
| Questor : Hikma Pharmaceuticals | 13-Mar-2014 | Telegraph |
| Investment Column:BTG | 06-Oct-2011 | The Independent |
| Investment Column:Genus | 09-Sep-2011 | The Independent |
| Questor :Dechra Pharmaceuticals | 08-Sep-2011 | Telegraph |
| Price | 28,977.72 |
| Closing Price Change | -47.77 |
| % Change | -0.16 % |
| 20-Feb-26 Close | 28,977.72 |
You are here: research